BRN2 is a transcriptional repressor of CDH13 (T-cadherin) in melanoma cells
about
Clinicopathological significance and potential drug target of T-cadherin in NSCLC.Adiponectin in inflammatory and immune-mediated diseasesAssociation of T-cadherin levels with the response to neoadjuvant chemotherapy in locally advanced breast cancer.MITF and PAX3 Play Distinct Roles in Melanoma Cell Migration; Outline of a "Genetic Switch" Theory Involving MITF and PAX3 in Proliferative and Invasive Phenotypes of Melanoma.Prognostic significance of CDH13 hypermethylation and mRNA in NSCLC.MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens.DCC is expressed in a CD166-positive subpopulation of chondrocytes in human osteoarthritic cartilage and modulates CRE activity.Neural lineage-specific homeoprotein BRN2 is directly involved in TTF1 expression in small-cell lung cancer.T-cadherin association with clinicopathological features and prognosis in axillary lymph node-positive breast cancer.T-cadherin is associated with prognosis in triple-negative breast cancerCapsaicin Inhibited Aggressive Phenotypes through Downregulation of Tumor-Associated NADH Oxidase (tNOX) by POU Domain Transcription Factor POU3F2.Egr-1 increases angiogenesis in cartilage via binding Netrin-1 receptor DCC promoter.
P2860
Q34783319-6D3C2B51-0F07-4E79-9636-BD502C190DD6Q37164707-617F0DD6-737C-46AD-9332-AC7A79CA3442Q37706693-861FF277-0516-4387-95BF-6FF6AFCBB379Q38142161-6FD06247-FAE7-4017-8E81-A732E5E208E7Q38266450-2B98B8C6-77F8-4933-9CA8-0164D5488F4CQ38932131-1BC61171-527E-483F-968F-4A51318BA10AQ38981150-6A52D437-8A8A-457F-9887-26E1CB6506B8Q39203133-BD83FC91-1005-40E3-9454-FEF4AD5B98FCQ41442001-033E60E5-A8F2-4BB5-BDD9-6C4B9514355EQ41612892-AC834D07-F653-4F78-B081-1E36655CA43BQ51715838-0FB7E205-83E4-4FBB-A50B-5F1A1D49E05FQ55048482-A08A823B-737E-4E16-8BD2-58DE8DD0A142
P2860
BRN2 is a transcriptional repressor of CDH13 (T-cadherin) in melanoma cells
description
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2012
@ast
im Dezember 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2012/12/01)
@sk
vědecký článek publikovaný v roce 2012
@cs
wetenschappelijk artikel (gepubliceerd op 2012/12/01)
@nl
наукова стаття, опублікована в грудні 2012
@uk
مقالة علمية (نشرت في ديسمبر 2012)
@ar
name
BRN2 is a transcriptional repressor of CDH13 (T-cadherin) in melanoma cells
@ast
BRN2 is a transcriptional repressor of CDH13 (T-cadherin) in melanoma cells
@en
BRN2 is a transcriptional repressor of CDH13 (T-cadherin) in melanoma cells
@nl
type
label
BRN2 is a transcriptional repressor of CDH13 (T-cadherin) in melanoma cells
@ast
BRN2 is a transcriptional repressor of CDH13 (T-cadherin) in melanoma cells
@en
BRN2 is a transcriptional repressor of CDH13 (T-cadherin) in melanoma cells
@nl
prefLabel
BRN2 is a transcriptional repressor of CDH13 (T-cadherin) in melanoma cells
@ast
BRN2 is a transcriptional repressor of CDH13 (T-cadherin) in melanoma cells
@en
BRN2 is a transcriptional repressor of CDH13 (T-cadherin) in melanoma cells
@nl
P2093
P2860
P1476
BRN2 is a transcriptional repressor of CDH13 (T-cadherin) in melanoma cells
@en
P2093
Lisa Ellmann
Manjunath B. Joshi
Silke Kuphal
Therese J. Resink
P2860
P2888
P304
P356
10.1038/LABINVEST.2012.140
P577
2012-12-01T00:00:00Z
P5875
P6179
1020019457